New York J 843: Memorializing Governor Kathy Hochul to proclaim June 2025, as Meningitis B Awareness Month in the State of New York
Status: ADOPTED (as of 2025-04-29)
State: New York · Session: 2025-2026 · Bill: J 843
Sponsors: Gustavo Rivera
Bill Text
Bill Search and Legislative Information | New York State Assembly • • • • • • • • Skip to main content New York State Assembly Speaker Carl E. Heastie --> --> --> • Assembly Members • Legislative Info • Public Hearings • Speaker's Press • Assembly Reports • Committees & More • Bill Search Home • Laws • Legislative Calendar • Public Hearing Schedule • Assembly Calendars • Assembly Committee Agenda Javascript must be enabled to properly view this page. - This bill is not active in this session. Bill No.: • Summary • Actions • Committee Votes • Floor Votes • Memo • Text • LFIN • Chamber Video/Transcript J00843 Summary: BILL NOJ00843   SAME ASNo Same As   SPONSORRIVERA   COSPNSR   MLTSPNSR     Go to top J00843 Actions: BILL NOJ00843   04/22/2025REFERRED TO FINANCE 04/29/2025REPORTED TO CALENDAR FOR CONSIDERATION 04/29/2025ADOPTED Go to topJ00843 Committee Votes: Go to topJ00843 Floor Votes: There are no Assembly votes for this bill in this legislative session. Go to topJ00843 Text: Senate Resolution No. 843 BY: Senator RIVERA MEMORIALIZING Governor Kathy Hochul to proclaim June 2025, as Meningitis B Awareness Month in the State of New York WHEREAS, It is the custom of this Legislative Body to increase awareness of serious illnesses that affect the lives of our citizens; and WHEREAS, It is the sense of this Legislative Body to memorialize Governor Kathy Hochul to proclaim June 2025, as Meningitis B Awareness in the State of New York, in conjunction with the observance of National Meningitis Month; and WHEREAS, Meningococcal disease, more commonly referred to as bacterial meningitis, is any infection caused by the bacterium Neisseria meningitidis; and WHEREAS, Meningococcal disease is uncommon; however, when it strikes, its flu-like symptoms make diagnosis difficult; and WHEREAS, Meningococcal disease can cause serious illness such as infection of the lining of the brain and spinal column (meningitis) or blood infections (sepsis); the disease strikes quickly and can lead to severe or permanent disabilities, such as hearing loss, brain damage, seizures, limb amputation or even lead to death within 24-48 hours; and WHEREAS, Although 1 in 10 people are carriers for this bacteria with no signs or symptoms of disease, sometimes Neisseria meningitidis bacteria can cause illness; and WHEREAS, There are different strains of bacterial meningitis, including serogroups A, C, W, Y, and B, and vaccines exist to help provide protection against all the serogroups commonly seen in the United States; and WHEREAS, The single best way to help prevent all common strains of meningococcal disease is to be vaccinated with both a MenACWY vaccine and a separate MenB vaccine; and WHEREAS, Meningococcal disease is spread from person to person via the exchange of the bacteria through respiratory and throat secretions during close or lengthy contact, such as sharing beverages or eating utensils, kissing, or spending time in close contact with someone who is sick or who carries the bacteria; and WHEREAS, Community settings in which large groups of people gather, like college campuses, can increase the risk of the spread of meningococcal disease; and WHEREAS, Because of the way meningitis is spread, through close personal contact, and that the social behavior of young adults ages 16-23 increases their risk of contracting the disease; students in dormitory settings and crowded events, are particularly vulnerable to meningococcal disease; and WHEREAS, While vaccines for serogroups A, C, W, and Y have been available for many years, prior to 2014, there were no vaccines available for serogroup B; and WHEREAS, Despite the existence of a serogroup B vaccine, meningitis B has been responsible for all U.S. college campus outbreaks since 2011, with some cases resulting in death; and WHEREAS, Because the B strain of meningitis requires a new, separate vaccination, students heading to college may mistakenly think that if they received the MenACWY vaccine that they are protected against all strains and may not realize they are not protected against the B strain; and WHEREAS, According to the Centers for Disease Control, Neisseria meningitidis serogroup B accounts for approximately half of all meningococcal cases among persons aged 16-23 years in the U.S.; and WHEREAS, Vaccination for serogroups A, C, W and Y is routinely recommended by the Centers for Disease Control and Prevention; and WHEREAS, The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommends that decisions to vaccinate adolescents and young adults 16 through 23 years of age against serogroup B meningococcal disease should be made at the individual level with health care providers through shared clinical decision making; and WHEREAS, In accordance with ACIP recomm
View New York J 843 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.